BigHat Biosciences[ PART ]
A clinical-stage, AI-driven protein therapeutics platform company
Series C$75M2026-09-23Verified against 4 of 28 sources
Named on 5 rounds in the feed, most often at Series B and in Biotech.
Rounds from ~ 2024-07 to 2026-10-26
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
DropGenie A functional biology company generating decision-ready discovery data from patient-derived cells | Seed Verified against 1 of 9 sources | $5M | 2026-10-26 | [ PART ] |
BigHat Biosciences A clinical-stage, AI-driven protein therapeutics platform company | Series C Verified against 4 of 28 sources | $75M | 2026-09-23 | [ PART ] |
N-Power Medicine A biotech infrastructure company for oncology trials | Series B Verified against 3 sources | $32M | 2026-09-01 | [ PART ] |
PreciseDx A digital pathology platform that uses AI to assess breast cancer risk | Funding round Developing, 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $11M | 2025-06-18 | [ PART ] |
N-Power Medicine A biotech infrastructure company for oncology trials | Series B Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | n/a | ~ 2024-07 | [ LEAD ] |